By Priscila Mayumi Kashiwabara
5 de July de 2021
Personalised medicine in Brazil: IP and regulatory challenges
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2021, a supplement to IAM, published by Law Business Research – IP Division.
Click below to access the full chapter.
Back
Share:
Last by Priscila Mayumi Kashiwabara
14 de August de 2026
INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed … INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
1 de July de 2026
INPI Ordinance No. 80/2026 and Second Medical Use Patents
INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents
29 de May de 2026
Kasznar Leonardos has been ranked by IAM Patent 1000
It is with great honor that we announce that we have once again been ranked in the IAM Patent 1000. In the … Kasznar Leonardos has been ranked by IAM Patent 1000